Intermethod variability in TSH-receptor antibody measurement: Implication for the diagnosis of graves disease and for the follow-up of graves ophthalmopathy

Clinical Chemistry

Volumn 55, Issue 1, 2009, Pages 183-186

  Massart, Catherine ^a,b   Sapin, Rémy ^c,d   Gibassier, Jacqueline ^a   Agin, Arnaud ^c,d   D'Herbomez, Michèle ^e,f  

^a RENNES UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^d UNIVERSITÉ DE STRASBOURG   (France)

^e LILLE UNIVERSITY HOSPITAL   (France)

^f UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY;

ADULT; AGED; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENDOCRINE OPHTHALMOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAVES DISEASE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; SENSITIVITY AND SPECIFICITY;

SUS;

EID: 58149252075     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2008.115162     Document Type: Article

References (20)

1. Rees Smith B, McLachlan SM, Furmaniak J. Autoantibodies to the thyrotropin receptor. Endocr Rev 1988;9:106-21.
2. Shewring G, Rees Smith B. An improved radioceptor assay for TSH receptor antibodies. Clin Endocrinol (Oxf) 1982;17:409-17.
3. Costagliola S, Morgenthaler NG, Hoermann R, Badenhoop K, Struck J, Freitag D, et al. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. J Clin Endocrinol Metab 1999;84:90-7.
4. Bulow Pedersen I, Knudsen N, Perrild H, Ovesen L, Laurberg P. TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays. Clin Endocrinol 2001;55:381-90.
5. Massart C, Orgiazzi J, Maugendre D. Second generation of TSH-receptor antibodies in sera from patients with Graves' disease: comparison with thyroid stimulating antibody assay. Clin Chim Acta 2001;304:39-47.
6. Maugendre D, Massart C. Clinical value of human TSH receptor binding antibody determination in the follow-up of anti-thyroid drug treated Graves' disease: comparison with thyroid stimulating antibody assay. Clin Endocrinol (Oxf) 2001;54:89-96.
7. Zöphel K, Von Landenberg P, Roggenbuck D, Wunderlich G, Kotzerke J, Lackner KJ. Are porcine and human TSH receptor antibody measurements comparable? Clin Lab 2008;54:1-8.
8. Rees Smith B, Bolton J, Young S, et al. A new assay for thyrotropin receptor autoantibodies. Thyroid 2004;14:830-5.
9. Liu C, Hermsen D, Domberg J, Graeber C, Hautzel H, Duan K, et al. Comparison of M22-based ELISA and human-TSH-receptor-based luminescence assay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases. Horm Metab Res 2008;40:479-83.
10. Gassner D, Golla R, Stock W, Sanders J, Rees Smith B. First rapid and automated immunoassay for TSH receptor antibodies [abstract]. In: Grüters A, Alvarez CV, Bornstein S, Christin-Maitre Enerbäck S, Erdogan M, et al. European Congress of Endocrinology 2008; 2008 May 3-7; Berlin, Germany. Vol. 16. BioScientifica: Bristol (UK); 2008. P819 (poster no.). http://www.endocrine- abstracts. org/ea/0016/default.htm (Accessed December 2008).
11. Massart C, Hody B, Mouchel L, Edan G, Nicol M. Assays for thyrotropin-receptor binding and thyroid-stimulating antibodies in sera from patients with Graves' disease. Clin Chem 1986;32:1332-5.
12. Massart C, Gibassier J, Vérité F, Fergelot P, Maugendre D. Measurement of thyroid-stimulating immunoglobulins using Chinese Hamster Ovary cells transfected with cloned human thyrotropin receptor, compared with an assay using human thyrocytes. Clin Chim Acta 2000;29:67-81.
13. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
14. Spencer CA, Takeuchi M, Kararosyan M. Current status and performance goals for serum thyrotropin (TSH) assays. Clin Chem 1996;42:140-5.
15. Morgenthaler NG, Ho SC, Minich WB. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites. J Clin Endocrinol Metab 2007;92:1058-65.
16. Rapoport B, McLachlan SM. The thyrotropin receptor in Graves' disease. Thyroid 2007;17:911-22.
17. Gerding MN, van der Meer JWC, Broenink M, Bakker O, Wiersinga M, Prummel MF. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy. Clin Endocrinol (Oxf) 2000;52:267-71.
18. Eckstein AK, Plicht M, Lax H, Neuhäuser M, Mann K, Lederbogen S, et al. Thyrotropin receptor autoantibodies are independent risk factors for Graves ophthalmopathy and help to predict severity and outcome of the disease. J Clin Endocrinol Metab 2006;91:3464-70.
19. Shibayama K, Ohyama Y, Yokota S, Takubo N, Matsuura N. Assays for thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins in children with Graves' disease. Endocr J 2005;52:505-10.
20. Zimmermann-Belsing T, Nygaard B, Rasmussen AK, Feldt-Rasmussen U. Use of the second generation TRAK human assay did not improve prediction of relapse after antithyroid medical therapy of Graves' disease. Eur J Endocrinol 2002;146:173-7.